EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Proliferative Diabetic Retinopathy with Panretinal Photocoagulation Outcomes in patients gtoreq70 years versus 70 years



Treatment of Proliferative Diabetic Retinopathy with Panretinal Photocoagulation Outcomes in patients gtoreq70 years versus 70 years



IOVS 40(4): S192, March 15




(PDF 0-2 workdays service: $29.90)

Accession: 035980586

Download citation: RISBibTeXText



Related references

Choroidal Thickness Changes In Proliferative Diabetic Retinopathy Treated With Panretinal Photocoagulation Versus Panretinal Photocoagulation With Intravitreal Bevacizumab. Retina 36(10): 1997-2005, 2016

Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy. Seminars in Ophthalmology 16(1): 12-18, 2004

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial. American Journal of Ophthalmology 170(): 206-213, 2016

Results of panretinal photocoagulation in preproliferative and proliferative ischemic diabetic retinopathy: apropos of 235 eyes followed for 6 months to 8 years. Bulletin des Societes D'ophtalmologie de France 86(11): 1363-1366, 1986

Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy. Acta Ophthalmologica 90(7): E573-E574, 2013

Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 89(7): 772-779, 1982

Outcomes of panretinal photocoagulation in proliferative diabetic retinopathy. Investigative Ophthalmology & Visual Science 38(4 PART 1-2): S349, 1997

Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Documenta Ophthalmologica. Advances in Ophthalmology 124(3): 225-236, 2012

One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy. American Journal of Ophthalmology 129(2): 178-185, 2000

Comparison between panretinal photocoagulation and panretinal photocoagulation plus intravitreal bevacizumab in proliferative diabetic retinopathy. Journal of Ayub Medical College, Abbottabad 24(3-4): 10-13, 2014

Pulsatile ocular blood flow changes after panretinal photocoagulation treatment in patients with proliferative diabetic retinopathy. Turkish Journal of Medical Sciences 44(3): 524-529, 2015

Effect of panretinal photocoagulation treatment on vision-related quality of life of patients with proliferative diabetic retinopathy. Retina 33(4): 756-761, 2013

Effects of laser panretinal photocoagulation treatment on the photopic and scotopic A and B-wave in patients with proliferative diabetic retinopathy. IOVS 39(4): S180, March 15, 1998

The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes. European Journal of Ophthalmology 14(6): 538-542, 2005

Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. Acta Ophthalmologica 89(7): E567-E572, 2012